[Bacterial dermohypodermitis and necrotizing fascitis: 104-case series from Togo].
Identifieur interne : 004461 ( Ncbi/Merge ); précédent : 004460; suivant : 004462[Bacterial dermohypodermitis and necrotizing fascitis: 104-case series from Togo].
Auteurs : B. Saka [Togo] ; K. Kombaté ; A. Mouhari-Toure ; S. Akakpo ; T. Boukari ; P. Pitché ; K. Tchangaï-WallaSource :
- Medecine tropicale : revue du Corps de sante colonial [ 0025-682X ] ; 2011.
Descripteurs français
- KwdFr :
- Adolescent, Adulte, Adulte d'âge moyen, Antibactériens (usage thérapeutique), Bactéries à Gram négatif (isolement et purification), Benzylpénicilline (usage thérapeutique), Durée du séjour, Enfant, Facteurs de risque, Fasciite nécrosante (diagnostic), Fasciite nécrosante (microbiologie), Fasciite nécrosante (traitement médicamenteux), Fasciite nécrosante (épidémiologie), Femelle, Humains, Hôpitaux universitaires, Infections opportunistes liées au SIDA (diagnostic), Infections opportunistes liées au SIDA (microbiologie), Infections opportunistes liées au SIDA (traitement médicamenteux), Infections opportunistes liées au SIDA (épidémiologie), Mâle, Prévention secondaire, Résultat thérapeutique, Staphylococcus aureus (isolement et purification), Streptococcus pyogenes (isolement et purification), Sujet immunodéprimé, Sujet âgé, Sujet âgé de 80 ans ou plus, Togo (épidémiologie), Érysipèle (diagnostic), Érysipèle (microbiologie), Érysipèle (traitement médicamenteux), Érysipèle (épidémiologie), Études rétrospectives.
- MESH :
- diagnostic : Fasciite nécrosante, Infections opportunistes liées au SIDA, Érysipèle.
- isolement et purification : Bactéries à Gram négatif, Staphylococcus aureus, Streptococcus pyogenes.
- microbiologie : Fasciite nécrosante, Infections opportunistes liées au SIDA, Érysipèle.
- traitement médicamenteux : Fasciite nécrosante, Infections opportunistes liées au SIDA, Érysipèle.
- usage thérapeutique : Antibactériens, Benzylpénicilline.
- épidémiologie : Fasciite nécrosante, Infections opportunistes liées au SIDA, Togo, Érysipèle.
- Adolescent, Adulte, Adulte d'âge moyen, Durée du séjour, Enfant, Facteurs de risque, Femelle, Humains, Hôpitaux universitaires, Mâle, Prévention secondaire, Résultat thérapeutique, Sujet immunodéprimé, Sujet âgé, Sujet âgé de 80 ans ou plus, Études rétrospectives.
- Wicri :
- geographic : Togo.
English descriptors
- KwdEn :
- AIDS-Related Opportunistic Infections (diagnosis), AIDS-Related Opportunistic Infections (drug therapy), AIDS-Related Opportunistic Infections (epidemiology), AIDS-Related Opportunistic Infections (microbiology), Adolescent, Adult, Aged, Aged, 80 and over, Anti-Bacterial Agents (therapeutic use), Child, Erysipelas (diagnosis), Erysipelas (drug therapy), Erysipelas (epidemiology), Erysipelas (microbiology), Fasciitis, Necrotizing (diagnosis), Fasciitis, Necrotizing (drug therapy), Fasciitis, Necrotizing (epidemiology), Fasciitis, Necrotizing (microbiology), Female, Gram-Negative Bacteria (isolation & purification), Hospitals, University, Humans, Immunocompromised Host, Length of Stay, Male, Middle Aged, Penicillin G (therapeutic use), Retrospective Studies, Risk Factors, Secondary Prevention, Staphylococcus aureus (isolation & purification), Streptococcus pyogenes (isolation & purification), Togo (epidemiology), Treatment Outcome.
- MESH :
- chemical , therapeutic use : Anti-Bacterial Agents, Penicillin G.
- geographic , epidemiology : Togo.
- diagnosis : AIDS-Related Opportunistic Infections, Erysipelas, Fasciitis, Necrotizing.
- drug therapy : AIDS-Related Opportunistic Infections, Erysipelas, Fasciitis, Necrotizing.
- epidemiology : AIDS-Related Opportunistic Infections, Erysipelas, Fasciitis, Necrotizing.
- isolation & purification : Gram-Negative Bacteria, Staphylococcus aureus, Streptococcus pyogenes.
- microbiology : AIDS-Related Opportunistic Infections, Erysipelas, Fasciitis, Necrotizing.
- Adolescent, Adult, Aged, Aged, 80 and over, Child, Female, Hospitals, University, Humans, Immunocompromised Host, Length of Stay, Male, Middle Aged, Retrospective Studies, Risk Factors, Secondary Prevention, Treatment Outcome.
Abstract
The purpose of this retrospective study was to obtain data on the epidemiology, clinical features, and outcome of bacterial dermohypodermitis (BDH) observed in a hospital setting hospital in Lomé, Togo. Cases of BDH treated in dermatology and internal medicine of the Lomé university hospital center from January 1999 to December 2009 were reviewed. A total of 104 patients were hospitalized for BDH during the study period. Mean patient age was 42.9 +/- 16.1 years and sex ratio (M/F) was 0.89. Infection by HIV was detected in 10 of 37 patients in whom serology was performed. The site of erysipelas was located on the legs and feet in 93 cases (89.4%), entire lower limb in 4 (3.9%), upper limbs in 4 (3.9%), thighs in 2 (1.9%), and buttock in 1 (0.9%). The main local and systemic risk factors were existence of an entry site in 89 cases, use of depigmenting drugs in 11, HIV infection in 10, previous history of erysipelas in 9 cases, and lymphoedema in 8. First-line treatment used penicillin G in 90 cases. Seven patients presented necrotizing fasciitis. Necrotizing fasciitis was associated with HIV infection in 2 cases, use of non-steroidal anti-inflammatory drugs (NSAID) in 2, and use of depigmenting drugs in one. Two deaths were recorded in the necrotizing fasciitis group including one HIV-infected patient. Recurrence was observed in 8 patients and secondary complications such as lower limb elephantiasis occurred in 7 patients.
PubMed: 21695874
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 002566
- to stream PubMed, to step Curation: 002566
- to stream PubMed, to step Checkpoint: 002566
Links to Exploration step
pubmed:21695874Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[Bacterial dermohypodermitis and necrotizing fascitis: 104-case series from Togo].</title><author><name sortKey="Saka, B" sort="Saka, B" uniqKey="Saka B" first="B" last="Saka">B. Saka</name><affiliation wicri:level="1"><nlm:affiliation>Service de dermatologie, CHU Tokoin, Lomé, Togo. barthelemysaka@yahoo.fr</nlm:affiliation><country xml:lang="fr">Togo</country><wicri:regionArea>Service de dermatologie, CHU Tokoin, Lomé</wicri:regionArea><wicri:noRegion>Lomé</wicri:noRegion></affiliation></author><author><name sortKey="Kombate, K" sort="Kombate, K" uniqKey="Kombate K" first="K" last="Kombaté">K. Kombaté</name></author><author><name sortKey="Mouhari Toure, A" sort="Mouhari Toure, A" uniqKey="Mouhari Toure A" first="A" last="Mouhari-Toure">A. Mouhari-Toure</name></author><author><name sortKey="Akakpo, S" sort="Akakpo, S" uniqKey="Akakpo S" first="S" last="Akakpo">S. Akakpo</name></author><author><name sortKey="Boukari, T" sort="Boukari, T" uniqKey="Boukari T" first="T" last="Boukari">T. Boukari</name></author><author><name sortKey="Pitche, P" sort="Pitche, P" uniqKey="Pitche P" first="P" last="Pitché">P. Pitché</name></author><author><name sortKey="Tchangai Walla, K" sort="Tchangai Walla, K" uniqKey="Tchangai Walla K" first="K" last="Tchangaï-Walla">K. Tchangaï-Walla</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2011">2011</date><idno type="RBID">pubmed:21695874</idno><idno type="pmid">21695874</idno><idno type="wicri:Area/PubMed/Corpus">002566</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002566</idno><idno type="wicri:Area/PubMed/Curation">002566</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002566</idno><idno type="wicri:Area/PubMed/Checkpoint">002566</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002566</idno><idno type="wicri:Area/Ncbi/Merge">004461</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">[Bacterial dermohypodermitis and necrotizing fascitis: 104-case series from Togo].</title><author><name sortKey="Saka, B" sort="Saka, B" uniqKey="Saka B" first="B" last="Saka">B. Saka</name><affiliation wicri:level="1"><nlm:affiliation>Service de dermatologie, CHU Tokoin, Lomé, Togo. barthelemysaka@yahoo.fr</nlm:affiliation><country xml:lang="fr">Togo</country><wicri:regionArea>Service de dermatologie, CHU Tokoin, Lomé</wicri:regionArea><wicri:noRegion>Lomé</wicri:noRegion></affiliation></author><author><name sortKey="Kombate, K" sort="Kombate, K" uniqKey="Kombate K" first="K" last="Kombaté">K. Kombaté</name></author><author><name sortKey="Mouhari Toure, A" sort="Mouhari Toure, A" uniqKey="Mouhari Toure A" first="A" last="Mouhari-Toure">A. Mouhari-Toure</name></author><author><name sortKey="Akakpo, S" sort="Akakpo, S" uniqKey="Akakpo S" first="S" last="Akakpo">S. Akakpo</name></author><author><name sortKey="Boukari, T" sort="Boukari, T" uniqKey="Boukari T" first="T" last="Boukari">T. Boukari</name></author><author><name sortKey="Pitche, P" sort="Pitche, P" uniqKey="Pitche P" first="P" last="Pitché">P. Pitché</name></author><author><name sortKey="Tchangai Walla, K" sort="Tchangai Walla, K" uniqKey="Tchangai Walla K" first="K" last="Tchangaï-Walla">K. Tchangaï-Walla</name></author></analytic><series><title level="j">Medecine tropicale : revue du Corps de sante colonial</title><idno type="ISSN">0025-682X</idno><imprint><date when="2011" type="published">2011</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>AIDS-Related Opportunistic Infections (diagnosis)</term><term>AIDS-Related Opportunistic Infections (drug therapy)</term><term>AIDS-Related Opportunistic Infections (epidemiology)</term><term>AIDS-Related Opportunistic Infections (microbiology)</term><term>Adolescent</term><term>Adult</term><term>Aged</term><term>Aged, 80 and over</term><term>Anti-Bacterial Agents (therapeutic use)</term><term>Child</term><term>Erysipelas (diagnosis)</term><term>Erysipelas (drug therapy)</term><term>Erysipelas (epidemiology)</term><term>Erysipelas (microbiology)</term><term>Fasciitis, Necrotizing (diagnosis)</term><term>Fasciitis, Necrotizing (drug therapy)</term><term>Fasciitis, Necrotizing (epidemiology)</term><term>Fasciitis, Necrotizing (microbiology)</term><term>Female</term><term>Gram-Negative Bacteria (isolation & purification)</term><term>Hospitals, University</term><term>Humans</term><term>Immunocompromised Host</term><term>Length of Stay</term><term>Male</term><term>Middle Aged</term><term>Penicillin G (therapeutic use)</term><term>Retrospective Studies</term><term>Risk Factors</term><term>Secondary Prevention</term><term>Staphylococcus aureus (isolation & purification)</term><term>Streptococcus pyogenes (isolation & purification)</term><term>Togo (epidemiology)</term><term>Treatment Outcome</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adolescent</term><term>Adulte</term><term>Adulte d'âge moyen</term><term>Antibactériens (usage thérapeutique)</term><term>Bactéries à Gram négatif (isolement et purification)</term><term>Benzylpénicilline (usage thérapeutique)</term><term>Durée du séjour</term><term>Enfant</term><term>Facteurs de risque</term><term>Fasciite nécrosante (diagnostic)</term><term>Fasciite nécrosante (microbiologie)</term><term>Fasciite nécrosante (traitement médicamenteux)</term><term>Fasciite nécrosante (épidémiologie)</term><term>Femelle</term><term>Humains</term><term>Hôpitaux universitaires</term><term>Infections opportunistes liées au SIDA (diagnostic)</term><term>Infections opportunistes liées au SIDA (microbiologie)</term><term>Infections opportunistes liées au SIDA (traitement médicamenteux)</term><term>Infections opportunistes liées au SIDA (épidémiologie)</term><term>Mâle</term><term>Prévention secondaire</term><term>Résultat thérapeutique</term><term>Staphylococcus aureus (isolement et purification)</term><term>Streptococcus pyogenes (isolement et purification)</term><term>Sujet immunodéprimé</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term><term>Togo (épidémiologie)</term><term>Érysipèle (diagnostic)</term><term>Érysipèle (microbiologie)</term><term>Érysipèle (traitement médicamenteux)</term><term>Érysipèle (épidémiologie)</term><term>Études rétrospectives</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Anti-Bacterial Agents</term><term>Penicillin G</term></keywords><keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Togo</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>AIDS-Related Opportunistic Infections</term><term>Erysipelas</term><term>Fasciitis, Necrotizing</term></keywords><keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Fasciite nécrosante</term><term>Infections opportunistes liées au SIDA</term><term>Érysipèle</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>AIDS-Related Opportunistic Infections</term><term>Erysipelas</term><term>Fasciitis, Necrotizing</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>AIDS-Related Opportunistic Infections</term><term>Erysipelas</term><term>Fasciitis, Necrotizing</term></keywords><keywords scheme="MESH" qualifier="isolation & purification" xml:lang="en"><term>Gram-Negative Bacteria</term><term>Staphylococcus aureus</term><term>Streptococcus pyogenes</term></keywords><keywords scheme="MESH" qualifier="isolement et purification" xml:lang="fr"><term>Bactéries à Gram négatif</term><term>Staphylococcus aureus</term><term>Streptococcus pyogenes</term></keywords><keywords scheme="MESH" qualifier="microbiologie" xml:lang="fr"><term>Fasciite nécrosante</term><term>Infections opportunistes liées au SIDA</term><term>Érysipèle</term></keywords><keywords scheme="MESH" qualifier="microbiology" xml:lang="en"><term>AIDS-Related Opportunistic Infections</term><term>Erysipelas</term><term>Fasciitis, Necrotizing</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Fasciite nécrosante</term><term>Infections opportunistes liées au SIDA</term><term>Érysipèle</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antibactériens</term><term>Benzylpénicilline</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Fasciite nécrosante</term><term>Infections opportunistes liées au SIDA</term><term>Togo</term><term>Érysipèle</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Aged</term><term>Aged, 80 and over</term><term>Child</term><term>Female</term><term>Hospitals, University</term><term>Humans</term><term>Immunocompromised Host</term><term>Length of Stay</term><term>Male</term><term>Middle Aged</term><term>Retrospective Studies</term><term>Risk Factors</term><term>Secondary Prevention</term><term>Treatment Outcome</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adolescent</term><term>Adulte</term><term>Adulte d'âge moyen</term><term>Durée du séjour</term><term>Enfant</term><term>Facteurs de risque</term><term>Femelle</term><term>Humains</term><term>Hôpitaux universitaires</term><term>Mâle</term><term>Prévention secondaire</term><term>Résultat thérapeutique</term><term>Sujet immunodéprimé</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term><term>Études rétrospectives</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Togo</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The purpose of this retrospective study was to obtain data on the epidemiology, clinical features, and outcome of bacterial dermohypodermitis (BDH) observed in a hospital setting hospital in Lomé, Togo. Cases of BDH treated in dermatology and internal medicine of the Lomé university hospital center from January 1999 to December 2009 were reviewed. A total of 104 patients were hospitalized for BDH during the study period. Mean patient age was 42.9 +/- 16.1 years and sex ratio (M/F) was 0.89. Infection by HIV was detected in 10 of 37 patients in whom serology was performed. The site of erysipelas was located on the legs and feet in 93 cases (89.4%), entire lower limb in 4 (3.9%), upper limbs in 4 (3.9%), thighs in 2 (1.9%), and buttock in 1 (0.9%). The main local and systemic risk factors were existence of an entry site in 89 cases, use of depigmenting drugs in 11, HIV infection in 10, previous history of erysipelas in 9 cases, and lymphoedema in 8. First-line treatment used penicillin G in 90 cases. Seven patients presented necrotizing fasciitis. Necrotizing fasciitis was associated with HIV infection in 2 cases, use of non-steroidal anti-inflammatory drugs (NSAID) in 2, and use of depigmenting drugs in one. Two deaths were recorded in the necrotizing fasciitis group including one HIV-infected patient. Recurrence was observed in 8 patients and secondary complications such as lower limb elephantiasis occurred in 7 patients.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">21695874</PMID><DateCreated><Year>2011</Year><Month>06</Month><Day>22</Day></DateCreated><DateCompleted><Year>2011</Year><Month>07</Month><Day>22</Day></DateCompleted><DateRevised><Year>2014</Year><Month>11</Month><Day>20</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0025-682X</ISSN><JournalIssue CitedMedium="Print"><Volume>71</Volume><Issue>2</Issue><PubDate><Year>2011</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Medecine tropicale : revue du Corps de sante colonial</Title><ISOAbbreviation>Med Trop (Mars)</ISOAbbreviation></Journal><ArticleTitle>[Bacterial dermohypodermitis and necrotizing fascitis: 104-case series from Togo].</ArticleTitle><Pagination><MedlinePgn>162-4</MedlinePgn></Pagination><Abstract><AbstractText>The purpose of this retrospective study was to obtain data on the epidemiology, clinical features, and outcome of bacterial dermohypodermitis (BDH) observed in a hospital setting hospital in Lomé, Togo. Cases of BDH treated in dermatology and internal medicine of the Lomé university hospital center from January 1999 to December 2009 were reviewed. A total of 104 patients were hospitalized for BDH during the study period. Mean patient age was 42.9 +/- 16.1 years and sex ratio (M/F) was 0.89. Infection by HIV was detected in 10 of 37 patients in whom serology was performed. The site of erysipelas was located on the legs and feet in 93 cases (89.4%), entire lower limb in 4 (3.9%), upper limbs in 4 (3.9%), thighs in 2 (1.9%), and buttock in 1 (0.9%). The main local and systemic risk factors were existence of an entry site in 89 cases, use of depigmenting drugs in 11, HIV infection in 10, previous history of erysipelas in 9 cases, and lymphoedema in 8. First-line treatment used penicillin G in 90 cases. Seven patients presented necrotizing fasciitis. Necrotizing fasciitis was associated with HIV infection in 2 cases, use of non-steroidal anti-inflammatory drugs (NSAID) in 2, and use of depigmenting drugs in one. Two deaths were recorded in the necrotizing fasciitis group including one HIV-infected patient. Recurrence was observed in 8 patients and secondary complications such as lower limb elephantiasis occurred in 7 patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Saka</LastName><ForeName>B</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Service de dermatologie, CHU Tokoin, Lomé, Togo. barthelemysaka@yahoo.fr</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kombaté</LastName><ForeName>K</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Mouhari-Toure</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Akakpo</LastName><ForeName>S</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Boukari</LastName><ForeName>T</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Pitché</LastName><ForeName>P</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Tchangaï-Walla</LastName><ForeName>K</ForeName><Initials>K</Initials></Author></AuthorList><Language>fre</Language><PublicationTypeList><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Dermo-hypodermites bactériennes et fasciites nécrosantes: 104 observations au togo.</VernacularTitle></Article><MedlineJournalInfo><Country>France</Country><MedlineTA>Med Trop (Mars)</MedlineTA><NlmUniqueID>8710146</NlmUniqueID><ISSNLinking>0025-682X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>Q42T66VG0C</RegistryNumber><NameOfSubstance UI="D010400">Penicillin G</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D017088" MajorTopicYN="N">AIDS-Related Opportunistic Infections</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004886" MajorTopicYN="N">Erysipelas</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019115" MajorTopicYN="N">Fasciitis, Necrotizing</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006090" MajorTopicYN="N">Gram-Negative Bacteria</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation & purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006785" MajorTopicYN="N">Hospitals, University</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016867" MajorTopicYN="Y">Immunocompromised Host</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010400" MajorTopicYN="N">Penicillin G</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055502" MajorTopicYN="N">Secondary Prevention</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013211" MajorTopicYN="N">Staphylococcus aureus</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation & purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013297" MajorTopicYN="N">Streptococcus pyogenes</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation & purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014037" MajorTopicYN="N" Type="Geographic">Togo</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2011</Year><Month>6</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2011</Year><Month>6</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2011</Year><Month>7</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">21695874</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Togo</li></country></list><tree><noCountry><name sortKey="Akakpo, S" sort="Akakpo, S" uniqKey="Akakpo S" first="S" last="Akakpo">S. Akakpo</name><name sortKey="Boukari, T" sort="Boukari, T" uniqKey="Boukari T" first="T" last="Boukari">T. Boukari</name><name sortKey="Kombate, K" sort="Kombate, K" uniqKey="Kombate K" first="K" last="Kombaté">K. Kombaté</name><name sortKey="Mouhari Toure, A" sort="Mouhari Toure, A" uniqKey="Mouhari Toure A" first="A" last="Mouhari-Toure">A. Mouhari-Toure</name><name sortKey="Pitche, P" sort="Pitche, P" uniqKey="Pitche P" first="P" last="Pitché">P. Pitché</name><name sortKey="Tchangai Walla, K" sort="Tchangai Walla, K" uniqKey="Tchangai Walla K" first="K" last="Tchangaï-Walla">K. Tchangaï-Walla</name></noCountry><country name="Togo"><noRegion><name sortKey="Saka, B" sort="Saka, B" uniqKey="Saka B" first="B" last="Saka">B. Saka</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004461 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 004461 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Ncbi
|étape= Merge
|type= RBID
|clé= pubmed:21695874
|texte= [Bacterial dermohypodermitis and necrotizing fascitis: 104-case series from Togo].
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i -Sk "pubmed:21695874" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |